Predict your next investment

Alveolus company logo
HEALTHCARE | Drug Development
alveolusbio.com

See what CB Insights has to offer

Founded Year

2021

Stage

Spinoff / Spinout | Alive

Total Raised

$4.5M

About Alveolus

Alveolus develops therapeutics for lung diseases such as live biotherapeutics for Bronchopulmonary Dysplasia (BPD), Chronic Obstructive Pulmonary Disease (COPD), Idiopathic Pulmonary Fibrosis (IPF), and Pulmonary Arterial Hypertension (PAH).

Alveolus Headquarter Location

1500 1st Ave N H102

Birmingham, Alabama, 35203,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.